GOPEP^™ DSR

Product Description

GOPEP^™ DSR is a thoughtfully designed combination of Pantoprazole — a proton pump inhibitor (PPI) — and Domperidone in its sustained-release (SR) form. This dual-action capsule reduces excess stomach acid while also addressing nausea, bloating and slow gastric emptying that often accompany acid reflux.

Manufactured by Trunexora Healthcare to GMP standards, GOPEP^™ DSR is a trusted choice for managing chronic acidity, GERD, peptic ulcer disease and stress-related dyspepsia — making it especially helpful for patients on long courses of NSAIDs or antibiotics.

Key Benefits

Composition

• Pantoprazole 40 mg (Enteric-coated) — Proton pump inhibitor for acid suppression.
• Domperidone 30 mg (Sustained Release) — Prokinetic and anti-emetic agent.
• Excipients q.s. as approved standards.

Indications

• Gastroesophageal reflux disease (GERD).
• Acid peptic disorders and peptic ulcer disease.
• Acidity, heartburn, and acid regurgitation.
• NSAID-induced gastric mucosal damage prevention.
• Functional dyspepsia and bloating with nausea.
• Zollinger-Ellison syndrome (under specialist supervision).

Dosage & Administration

• Adults: 1 capsule once daily, preferably 30–60 minutes before breakfast.
• Swallow whole with water — do not chew, crush or open the capsule.
• Take on an empty stomach for optimal absorption.
• Duration of treatment should be guided by your physician.

Safety Information

Use with caution in patients with hepatic impairment, cardiac arrhythmias, or those on QT-prolonging drugs. Long-term use of PPIs should be monitored. Not recommended in pregnancy and lactation unless prescribed. Discontinue and consult a physician if symptoms persist beyond 2 weeks.

Product Specifications

Frequently Asked Questions